|
Bunck, David N; Atsavapranee, Beatriz; Museth, Anna K et al. (2018) Modulating the Folding Landscape of Superoxide Dismutase?1 with Targeted Molecular Binders. Angew Chem Int Ed Engl 57:6212-6215
|
|
Masui, Kenta; Cavenee, Webster K; Mischel, Paul S (2016) Cancer metabolism as a central driving force of glioma pathogenesis. Brain Tumor Pathol 33:161-8
|
|
Poovathingal, Suresh Kumar; Kravchenko-Balasha, Nataly; Shin, Young Shik et al. (2016) Critical Points in Tumorigenesis: A Carcinogen-Initiated Phase Transition Analyzed via Single-Cell Proteomics. Small 12:1425-31
|
|
Masui, Kenta; Shibata, Noriyuki; Cavenee, Webster K et al. (2016) mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling. Bioessays 38:839-44
|
|
Das, Samir; Nag, Arundhati; Liang, JingXin et al. (2015) A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands. Angew Chem Int Ed Engl 54:13219-24
|
|
Zuckerman, Jonathan E; Gale, Aaron; Wu, Peiwen et al. (2015) siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA. Nucleic Acid Ther 25:53-64
|
|
Masui, Kenta; Cavenee, Webster K; Mischel, Paul S (2015) mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment. Brain Pathol 25:755-9
|
|
Deyle, Kaycie M; Farrow, Blake; Qiao Hee, Ying et al. (2015) A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1. Nat Chem 7:455-62
|
|
Hu-Lieskovan, Siwen; Homet Moreno, Blanca; Ribas, Antoni (2015) Excluding T Cells: Is ?-Catenin the Full Story? Cancer Cell 27:749-50
|
|
Heath, James R (2015) Nanotechnologies for biomedical science and translational medicine. Proc Natl Acad Sci U S A 112:14436-43
|
Showing the most recent 10 out of 135 publications
